Mirion Technologies
About: Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Employees: 2,860
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
2,371% more call options, than puts
Call options by funds: $17M | Put options by funds: $689K
37% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 67
28% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 36
17% more funds holding in top 10
Funds holding in top 10: 6 [Q4 2024] → 7 (+1) [Q1 2025]
3% more funds holding
Funds holding: 223 [Q4 2024] → 229 (+6) [Q1 2025]
1.39% less ownership
Funds ownership: 85.51% [Q4 2024] → 84.12% (-1.39%) [Q1 2025]
18% less capital invested
Capital invested by funds: $3.36B [Q4 2024] → $2.76B (-$606M) [Q1 2025]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
B. Riley Securities Yuan Zhi | 1%downside $22 | Buy Reiterated | 23 Jul 2025 |
Citigroup Andrew Kaplowitz | 8%upside $24 | Buy Maintained | 14 Jul 2025 |
Baird Robert Mason | 1%downside $22 | Outperform Maintained | 9 Jul 2025 |
Financial journalist opinion
Based on 7 articles about MIR published over the past 30 days
